Fundraising Fox

Ark

3 known investors

ark-biotech.com

Ark applies machine learning and AI to bioprocessing, replacing trial-and-error methods with hybrid predictive models to accelerate drug development and scale biotherapeutic manufacturing. The platform serves biopharmaceutical companies and biotech firms seeking to reduce R&D timelines and production costs.

AI & Machine LearningBiotechSaaS

Founders & leadership

ZH
Zheng HuangCo-Founder
YQ
Yossi QuintCo-Founder & CEO

Investors · 3

Competitors · 3

by search overlap

Companies competing with Ark for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Frequently asked questions

What does Ark do?
Ark applies machine learning and AI to bioprocessing, replacing trial-and-error methods with hybrid predictive models to accelerate drug development and scale biotherapeutic manufacturing. The platform serves biopharmaceutical companies and biotech firms seeking to reduce R&D timelines and production costs.
Who founded Ark?
Ark was founded by Zheng Huang, Yossi Quint.
Who are Ark's investors?
Ark's investors include HCVC, Primary Venture Partners, Siddhi Capital.